A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Stone, RM; Allen, SL; Pigneux, A; Stuart, RK; Wetzler, M; Rizzieri, D; Erba, HP; Damon, LE; Jang, JH; Tallman, MS; Warzocha, K; Masszi, T; Sekeres, MA; Miklos, E; Horst, H; Selleslag, DLD; Solomon, SR; Venugopal, P; Lundberg, AS; Powell, BL

Published Date

  • May 20, 2011

Published In

Volume / Issue

  • 29 / 15_suppl

Start / End Page

  • 6520 - 6520

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2011.29.15_suppl.6520